|
TMEM97 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.284200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.383600E-02 |
| Normal-vs-Stage2 |
2.926000E-01 |
| Normal-vs-Stage3 |
9.205400E-01 |
| Normal-vs-Stage4 |
7.157900E-02 |
| Stage1-vs-Stage2 |
8.215400E-01 |
| Stage1-vs-Stage3 |
2.305400E-01 |
| Stage1-vs-Stage4 |
2.680400E-02 |
| Stage2-vs-Stage3 |
4.926200E-01 |
| Stage2-vs-Stage4 |
3.511700E-02 |
| Stage3-vs-Stage4 |
2.991500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.176600E-01 |
| Normal-vs-AfricanAmerican |
5.950200E-02 |
| Normal-vs-Asian |
1.614960E-01 |
| Caucasian-vs-AfricanAmerican |
2.439400E-01 |
| Caucasian-vs-Asian |
1.345630E-01 |
| AfricanAmerican-vs-Asian |
1.097430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.662400E-02 |
| Normal-vs-Female |
5.728200E-02 |
| Male-vs-Female |
1.172140E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.620000E-01 |
| Normal-vs-Extreme_Weight |
4.856700E-03 |
| Normal-vs-Obese |
6.172600E-01 |
| Normal-vs-Extreme_Obese |
4.584300E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.809600E-02 |
| Normal_Weight-vs-Obese |
6.839400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.161200E-03 |
| Extreme_Weight-vs-Obese |
7.658100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.782200E-02 |
| Obese-vs-Extreme_Obese |
9.413400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.178400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.523200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.586580E-01 |
| Normal-vs-Age(81-100Yrs) |
1.838350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.620700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.539980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.483700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.279200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.770160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.606000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.450190E-02 |
| Normal-VS-Type2 PRCC |
1.415620E-01 |
| Normal-VS-KIRP CIMP |
5.739600E-02 |
| Normal-VS-Unclassified PRCC |
5.781400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.922000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.104000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.615700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.076090E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.243600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.320200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.914200E-01 |
| Normal-vs-N1 |
2.345000E-01 |
| Normal-vs-N2 |
1.294950E-01 |
| N0-vs-N1 |
2.959200E-01 |
| N0-vs-N2 |
1.905610E-02 |
| N1-vs-N2 |
8.261700E-02 |
|
|
